ATE298766T1 - Veränderung der herstellung von alpha-interferon - Google Patents

Veränderung der herstellung von alpha-interferon

Info

Publication number
ATE298766T1
ATE298766T1 AT99965674T AT99965674T ATE298766T1 AT E298766 T1 ATE298766 T1 AT E298766T1 AT 99965674 T AT99965674 T AT 99965674T AT 99965674 T AT99965674 T AT 99965674T AT E298766 T1 ATE298766 T1 AT E298766T1
Authority
AT
Austria
Prior art keywords
pyrrolidinone
methyl
aliphatic
production
cyclic
Prior art date
Application number
AT99965674T
Other languages
English (en)
Inventor
Asa Berglund
Original Assignee
Viranative Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viranative Ab filed Critical Viranative Ab
Application granted granted Critical
Publication of ATE298766T1 publication Critical patent/ATE298766T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
AT99965674T 1998-12-29 1999-12-22 Veränderung der herstellung von alpha-interferon ATE298766T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9804583A SE513313C2 (sv) 1998-12-29 1998-12-29 Modifierad interferonproduktion
PCT/SE1999/002446 WO2000039163A1 (en) 1998-12-29 1999-12-22 Modification of interferon alpha production

Publications (1)

Publication Number Publication Date
ATE298766T1 true ATE298766T1 (de) 2005-07-15

Family

ID=20413894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99965674T ATE298766T1 (de) 1998-12-29 1999-12-22 Veränderung der herstellung von alpha-interferon

Country Status (15)

Country Link
US (1) US6962695B1 (de)
EP (1) EP1141012B1 (de)
JP (1) JP4584456B2 (de)
AT (1) ATE298766T1 (de)
AU (1) AU2136200A (de)
CA (1) CA2354025C (de)
CZ (1) CZ301888B6 (de)
DE (1) DE69926013T2 (de)
ES (1) ES2244239T3 (de)
HK (1) HK1040086B (de)
HU (1) HU227164B1 (de)
NO (1) NO328424B1 (de)
PT (1) PT1141012E (de)
SE (1) SE513313C2 (de)
WO (1) WO2000039163A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE513313C2 (sv) * 1998-12-29 2000-08-21 Bionative Ab Modifierad interferonproduktion
JP2009298752A (ja) * 2008-06-17 2009-12-24 Shiseido Co Ltd 皮膚外用剤組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932617A (en) * 1974-05-24 1976-01-13 The Upjohn Company Interferon induction
US4027021A (en) 1974-08-23 1977-05-31 The Upjohn Company Interferon induction
CS215108B2 (en) 1977-07-15 1982-07-30 Wellcome Found Method of making the interferrone
DE2961658D1 (en) 1978-05-17 1982-02-18 Thomae Gmbh Dr K Process for preparing human interferon
JPS56135420A (en) * 1980-03-26 1981-10-22 Fumiaki Taguchi Suppressive substance of virus and its preparation
IT1172270B (it) * 1982-06-21 1987-06-18 Wellcome Found Procedimento per la produzione di interferon
SE513313C2 (sv) * 1998-12-29 2000-08-21 Bionative Ab Modifierad interferonproduktion

Also Published As

Publication number Publication date
WO2000039163A1 (en) 2000-07-06
CZ20011951A3 (cs) 2002-02-13
NO20013243D0 (no) 2001-06-28
DE69926013T2 (de) 2006-05-18
DE69926013D1 (de) 2005-08-04
HUP0104761A3 (en) 2004-07-28
HK1040086A1 (en) 2002-05-24
ES2244239T3 (es) 2005-12-01
AU2136200A (en) 2000-07-31
HK1040086B (zh) 2006-01-20
SE513313C2 (sv) 2000-08-21
CA2354025A1 (en) 2000-07-06
JP4584456B2 (ja) 2010-11-24
CA2354025C (en) 2012-05-22
SE9804583L (sv) 2000-06-30
PT1141012E (pt) 2006-06-30
JP2002533112A (ja) 2002-10-08
US6962695B1 (en) 2005-11-08
NO20013243L (no) 2001-06-28
EP1141012A1 (de) 2001-10-10
CZ301888B6 (cs) 2010-07-21
SE9804583D0 (sv) 1998-12-29
HUP0104761A2 (hu) 2002-04-29
HU227164B1 (en) 2010-09-28
EP1141012B1 (de) 2005-06-29
NO328424B1 (no) 2010-02-15

Similar Documents

Publication Publication Date Title
NL990030I1 (nl) Derivaten en analogen van 2-deoxy-2,3-didehydro-N-acetylneuraminezuur en het gebruik ervan als antivirale middelen.
BR9814361A (pt) Inibição de quinase raf usando uréiasheterocìclicas substituìdas por arila eheteroarila
BR9913406A (pt) Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção
DK0653439T3 (da) Stabiliserede oligonukleotider og anvendelse heraf
CY1105344T1 (el) Αμινουχα παραγωγα της διυδρο- 1,3,5 - τριαζινης και οι εφαρμογες τους στη θepαπευτικη
HRP20050417B1 (hr) Antiviralni derivati nukleozida
DE60143672D1 (de) Modifizierte nukleoside zur behandlung von virusinfektionen und abnormaler zellulärer proliferation
DE69025529D1 (de) Weitere antivirale Pyrimidin-Nukleosiden
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
ATE355380T1 (de) Methode zur selektiven inaktivierung der viralen replication
ATE254132T1 (de) Antivirale pyrimidin nucleoside derivate
DE60039729D1 (de) N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen
PT97754A (pt) Processo para a preparacao de composicoes farmaceuticas contendo pelo menos um agente inibidor da poli-(adp-ribose)-polimerase nomeadamente, uma amida aromatica, para o tratamento de infeccoes provocadas por virus
DE69932154D1 (de) Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen
ATE124412T1 (de) Antivirusderivate von (phosphonmethoxy)methoxy purin/pyrimidin.
PT96379A (pt) Processo de preparacao de ciclopropil-n-hidroxi-ureias,-carboxamidas e n-acil-n-hidroxiaminas substituidas e de composicoes farmaceuticas
DE69830241D1 (de) Verwendung von n-substituierten 1,5-dideoxy-1,5-imino-d-glucitol verbindungen in der kombinationstherapie der vom hepatitisvirus verursachten infektionen
ATE281179T1 (de) Zusammensetzungen zur behandlung von viralen infektionen und verfahren dafür
ATE298766T1 (de) Veränderung der herstellung von alpha-interferon
ATE77234T1 (de) Aromatische verbindungen mit amider struktur, derivate von aminobenzoesaeuren, hydroxybenzoesaeuren, zimtsaeuren, urocansaeuren und benzimidazolen, die uvb und/oder uva absorbieren.
DK1068209T3 (da) Fremgangsmåde til fremstilling af purinderivater og deres mellemprodukter
DK0443918T3 (da) Hidtil ukendte derivater af 20,21-dinoreburnamenin, deres fremstilling og anvendelse som lægemidler, samt mellemprodukter og farmaceutiske peæparater med indhold heraf
ES2187939T3 (es) Moleculas aisladas de acido nucleico codificantes de miembros de la familia ssx y utilizaciones de las mismas.
DE60044937D1 (de) Analoge des 5(e)bromovinyluracils und verwandte pyrimidinnucleoside als antivirale mittel und verwendungsmethoden
TH4918A (th) อนุพันธ์ของไพริมิดีน

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1141012

Country of ref document: EP

EEIH Change in the person of patent owner